Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

AIMS: To evaluate efficacy and safety of RLY5016 (a non-absorbed, orally administered, potassium [K(+)]-binding polymer) on serum K(+) levels in patients with chronic heart failure (HF) receiving standard therapy and spironolactone. METHODS AND RESULTS: One hundred and five patients with HF and a hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitt, Bertram, Anker, Stefan D., Bushinsky, David A., Kitzman, Dalane W., Zannad, Faiez, Huang, I-Zu
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Fasttrack Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069389/
https://www.ncbi.nlm.nih.gov/pubmed/21208974
http://dx.doi.org/10.1093/eurheartj/ehq502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069389/
https://www.ncbi.nlm.nih.gov/pubmed/21208974
http://dx.doi.org/10.1093/eurheartj/ehq502

Ejemplares similares